Abstract
Subsequent to the first α2-adrenergic receptor (α2-AR) gene cloning of α2-C10 from human platelet, cloning of the first rodent α2-AR cDNA, cA2-47, was reported. Based on the structural and limited pharmacological comparison, it was concluded that the rodent receptor is a molecular and pharmacological analog of the human receptor, which is pharmacologically classified as the α2A-AR. A later study slightly revised the structure of the human receptor. Thus, the precise structural comparison of the rat receptor to the human platelet receptor is no longer valid. Another rat α2-AR gene, RG20, was then cloned and was also found to be a structural analog of the human α2-C10. It, however, varied slightly from the α2A subtype pharmacology, but matched the newly defined α2D subtype pharmacology. It was, therefore, concluded that RG20 encodes the α2D subtype. The structural and pharmacological relationship of RG20 with cA2-47 is not known, although it has been tacitly assumed that both are the identical α2D receptor subtypes. The present study addresses this and other issues relating to the precise structural, genetic and pharmacological relationship of cA2-47 with the human platelet α2-C10 receptor, and also the localization of cA2-47 transcipt in certain rat tissues. The results show that the cA2-47 receptor shows a high degree of sequence identity to the α2-C10 receptor, yet important differences exist between them. The sequence identity of cA2-47 receptor to the RG20 receptor is almost, but not quite complete. The cA2-47 gene is not present in the human and the human gene is not present in the rat; that cA2-47 receptor subtype is pharmacologically similar to the RG20 receptor subtype, both being of the α2D subtype. The cA2-47 receptor transcript in addition to being found in the rat brain is present in the rat adrenal gland, testes, adrenocortical carcinoma and the bovine retina.
Similar content being viewed by others
References
Bylund DB: Comparison of3H-clonidine and3H-yohimbine binding. Possible subtypes of alpha-2 adrenergic receptors. Pharmacologist 23: 215, 1981
Cheung YD, Barnett DB, Nahorski SR:3H-Rauwolscine and3H-yohimbine binding to rat cerebral cortex and human platelet membranes: evidence for possible heterogeneity of alpha-2 adreneoceptors. Eur J Pharmac 84: 79–85, 1982
Latifpour J, Jones SB, Bylund DB: Characterization of3H-yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung. J Pharmac exp Ther 223: 606–611, 1982
Vizi ES, Ludvig N, Ronai AZ, Folly G: Dissociation of presynaptic α2-adrenoceptors following prazosin administration: presynaptic effect of prazosin. Eur J Pharmac 95: 287–290, 1983
Waterfall JF, Rhodes KF, Lattimer N: Studies of α2-adrenoceptor antagonist potencyin vitro: comparisons in tissues from rats, rabbits, dogs and humans. Clin Sci Suppl 10: 21s-24s, 1985
Jaiswal RK, Sharma RK: Purification and characterization of α2-adrenergic receptor from the rat adrenocortical carcinoma. Biochem Biophys Res Commun 130: 58–64, 1985
Reagan JW, Nakata H, Demarinis RM, Caron M, Lefkowitz RJ: Purification and characterization of the human platelets α2-adrenergic receptor. J Biol Chem 261: 3894–3900, 1986
Jaiswal RK, Marshak DR, Sharma RK: Molecular comparison of α2-adrenergic receptor from rat adrenocortical carcinoma and human blood platelet. Mol Cell Biochem 86, 41–53, 1989
Kobilka BK, Matsu H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW: Cloning, sequencing, and expression of the gene coding for the human platelet α2-adrenergic receptor. Science 238: 650–656, 1987
Guyer CA, Horstman DA, Wilson AL, Clark JD, Cragoe Jr EJ, Limbird LE: Cloning, sequencing and expression of the gene encoding the procine α2-adrenergic receptor. J Biol Chem 265: 17307–17317, 1990
Chalberg SC, Duda T, Rhine JA, Sharma RK: Molecular cloning, sequencing, and expression of an α2-adrenergic receptor complimentary CNA from rat brain. Mol Cell Biochem 97: 161–172, 1990
Lanier SM, Downing S, Duzic E, Homcy CJ: Isolation of rat genomic clones encoding subtypes of the α2-adrenergic receptor. Identification of a unique receptor subtype. J Biol Chem 266: 10470–10478, 1991
Simmonneaux VM, Ebadi M, Bylund DB: Identification and characterization of α2-adrenergic receptors in bovine pineal gland. Mol Pharmacol 40: 235–241, 1991
Michel AD, Loury DN, Whiting RL: Differences between α2-adrenoceptor in submaxillary gland and the α2A- and α2B-adrenoceptor subtypes. Br J Pharmacol 98: 890–897, 1989
Kurose H, Arriza JL, Lefkowitz RJ: Characterization of α2-adrenergic receptor subtype-specific antibodies. Mol Pharmacol 43: 444–450, 1993
Vidovic M, Cohen D, Hill CE: Identification of α2 adrenergic receptor gene expression in sympathetic neurones using polymerase chain reaction and in situ hybridization. Mol Brain Res 22: 49–56, 1994
Sanger F, Nicklen S, Coulsen AR: DNA sequencing with chain terminating-inhibitors. Proc Natl Acad Sci USA 74: 5463–5467, 1977
Sambrook J, Fritsh EF, Maniatis T: Molecular Cloning. Cold Spring Harbor, Laboratory Press, 1989
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680–683, 1970
Duda T, Chalberg S, Sharma RK: Genetic evidence for α2-adrenergic receptor subtypes in rat brain, heart and adrenal gland. Mol Cell Biochem 92: 69–75, 1990
Reagon JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK: Cloning and expression of a human kidney cDNA for an α2-adrenergic receptor subtype. Proc Natl Acad Sci USA 85: 6301–6305, 1988
Lomasney JW, Lorenz W, Allen LF, King K, Regan JW, Yang-Feng TL, Caron MG, Lefkowitz RJ: Expansion of the α2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci/USA 87: 5094–5098, 1990
Weinshank RL, Zgombic JM, Macchi M, Adham N, Lichtblau T, Branchek TA, Hartig PR: Cloning, expression, and pharmacological characterization of a human α2B-adrenergic receptor. Mol Pharmacol 38: 681–688, 1990
Bylund DB, Ray-Prenger C, Murphy TJ: Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245: 600–607, 1988
Blaxal HS, Murphy TJ, Baker JC, Ray C, Bylund DB: Characterization of the alpha-2C adrenergic receptor subtype in the oppossum kidney and in the OK cells. J Pharmacol Exp Ther 259: 323–329
MacKinnon Ac, Spedding M, Brown CM: α2-Adrenoceptors: more subtypes but fewer functional differences. TIPS 15: 119–123, 1994
Link R, Daunt D, Barsh G, Chruscinski A, Kobilka B: Cloning of two mouse genes encoding α2-adrenergic receptor subtypes and identification of a single amino acid in the mouse α2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42: 16–27, 1992
Schaad NC, Klein DC: Characterization of α2-adrenergic receptors on rat pineolocytes. Endocrinology 130: 2804–2810, 1992
Flordellis CS, Handy DE, Bresnahan MR, Zannis VI, Gavras H: Cloning and expression of a rat brain α2B-adrenergic receptor. Proc Natl Acad Sci USA 88: 1019–1023, 1991
Zeng DW, Harrison JK, D'Angelo DD, Barber CM, Tucker AL, Lu ZH, Lynch KR: Molecular characterization of a rat alpha 2B-adrenergic receptor. Proc Natl Acad Sci USA 87: 3102–3106, 1990
Voigt MM, McCune SK, Kanterman RY, Felder CC: The rat α2-C4 adrenergic receptor gene encodes a novel pharmacological subtype. FEBS Lett 278: 45–50, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wypijewski, K., Duda, T. & Sharma, R.K. Structural, genetic and pharmacological identity of the rat α2-adrenergic receptor subtype cA2-47 and its molecular characterization in rat adrenal, adrenocortical carcinoma and bovine retina. Mol Cell Biochem 144, 181–190 (1995). https://doi.org/10.1007/BF00944398
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00944398